Acadia Pharmaceuticals Inc.

About

At Acadia Pharmaceuticals, we are committed to advancing breakthroughs in neuroscience to elevate life. For over 30 years, we have been at the forefront of healthcare, alleviating the burdens of those living with debilitating diseases. Our passion lies in developing innovative therapies for neurological conditions. We are proud to have pioneered the first and only approved therapies for hallucinations and delusions associated with Parkinson's disease psychosis as well as treatments for Rett syndrome. Our work does not stop here; we continue to explore clinical-stage developments that target other critical areas, notably addressing unmet needs in Prader-Willi syndrome and Alzheimer’s disease psychosis. Our mission is unwavering: to ensure a brighter future for patients through science and innovation. Embracing collaboration and diverse perspectives is fundamental to our approach, as it helps foster an environment of creativity and commitment within our team. Here at Acadia, we also embrace our responsibility to help caregivers and provide necessary support to families impacted by these conditions. Our goal is to not merely treat symptoms but to enhance the quality of life for individuals and families as a whole, ensuring that we elevate life and make meaningful contributions to the neuroscience field.